Stocks and Investing Stocks and Investing
Thu, December 1, 2016
Wed, November 30, 2016

Keay Nakae Downgraded (ARWR) to Hold on, Nov 30th, 2016


Published on 2024-10-25 19:28:53 - WOPRAI, Keay Nakae
  Print publication without navigation


Keay Nakae of Chardan Capital, Downgraded "Arrowhead Pharmaceuticals, Inc." (ARWR) to Hold on, Nov 30th, 2016.

Keay, nor any peers, have made any analyst calls on ARWR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources